Livzon Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Livzon Pharmaceutical Group has a total shareholder equity of CN¥14.9B and total debt of CN¥4.1B, which brings its debt-to-equity ratio to 27.4%. Its total assets and total liabilities are CN¥24.9B and CN¥10.0B respectively. Livzon Pharmaceutical Group's EBIT is CN¥2.4B making its interest coverage ratio -12.8. It has cash and short-term investments of CN¥10.8B.
Key information
27.4%
Debt to equity ratio
CN¥4.09b
Debt
| Interest coverage ratio | -12.8x |
| Cash | CN¥10.81b |
| Equity | CN¥14.94b |
| Total liabilities | CN¥9.97b |
| Total assets | CN¥24.91b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LVZP.F's short term assets (CN¥16.6B) exceed its short term liabilities (CN¥9.0B).
Long Term Liabilities: LVZP.F's short term assets (CN¥16.6B) exceed its long term liabilities (CN¥960.3M).
Debt to Equity History and Analysis
Debt Level: LVZP.F has more cash than its total debt.
Reducing Debt: LVZP.F's debt to equity ratio has increased from 0% to 27.4% over the past 5 years.
Debt Coverage: LVZP.F's debt is well covered by operating cash flow (81.7%).
Interest Coverage: LVZP.F earns more interest than it pays, so coverage of interest payments is not a concern.